Table 2.

Treatment regimen versus visual outcomes.

	Nata Only (N=26)	Nata+Azoles (N=11)	Nata+Others (N=4)	Others (N=7)	P-value
Mean Initial BCVA	0.66 (0.73) 20/91	1.27 (0.99) 20/372	0.54 (0.38) 20/69	0.92 (0.99) 20/166	0.20*
Mean Follow up BCVA	0.24 (0.46) 20/35	1.74 (1.24) 20/1099	0.11 (0.08) 20/26	0.73 (1.12) 20/107	<0.001*
Mean BCVA improvement	0.43 (0.67)	−0.47† (1.23)	0.43 (0.31)	0.32 (0.42)	0.03*
Initial BCVA Better than or equal to 20/40	11 (42.3%)	1 (9.1%)	2 (50%)	2 (28.6%)	0.22**
Follow up BCVA Better than or equal to 20/40	22 (88%)	3 (27.3%)	4 (100%)	4 (66.7%)	0.001**
BCVA improve 2 or more lines	14 (56%)	2 (18.2%)	4 (100%)	3 (50%)	0.032**

^*Analysis of Variance (ANOVA) was performed.

^**Chi-Square Test

^†Mean follow up BCVA was worse than mean initial BCVA.